Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Radioactive iodine and the salivary glands.

Mandel SJ, Mandel L.

Thyroid. 2003 Mar;13(3):265-71. Review.

PMID:
12729475
2.

RETRACTED ARTICLE: Radiation sialadenitis induced by high-dose radioactive iodine therapy.

Jeong SY, Lee J.

Nucl Med Mol Imaging. 2010 Jun;44(2):102-9. doi: 10.1007/s13139-010-0027-y. Epub 2010 Apr 21. Review. Retraction in: Nucl Med Mol Imaging. 2014 Jun;48(2):171.

3.

Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer.

Ma C, Xie J, Chen Q, Wang G, Zuo S.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD007956. doi: 10.1002/14651858.CD007956.pub2. Review.

PMID:
19821441
4.

Salivary gland protection by amifostine in high-dose radioiodine treatment: results of a double-blind placebo-controlled study.

Bohuslavizki KH, Klutmann S, Brenner W, Mester J, Henze E, Clausen M.

J Clin Oncol. 1998 Nov;16(11):3542-9.

PMID:
9817273
5.

Salivary gland protection by amifostine in high-dose radioiodine therapy of differentiated thyroid cancer.

Bohuslavizki KH, Klutmann S, Bleckmann C, Brenner W, Lassmann S, Mester J, Henze E, Clausen M.

Strahlenther Onkol. 1999 Feb;175(2):57-61.

PMID:
10065139
6.

Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphy.

Raza H, Khan AU, Hameed A, Khan A.

Nucl Med Commun. 2006 Jun;27(6):495-9.

PMID:
16710103
7.

Radioprotection of salivary glands by amifostine in high-dose radioiodine therapy.

Bohuslavizki KH, Brenner W, Klutmann S, Hübner RH, Lassmann S, Feyerabend B, Lüttges J, Tinnemeyer S, Clausen M, Henze E.

J Nucl Med. 1998 Jul;39(7):1237-42.

8.
9.

Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?

Nakada K, Ishibashi T, Takei T, Hirata K, Shinohara K, Katoh S, Zhao S, Tamaki N, Noguchi Y, Noguchi S.

J Nucl Med. 2005 Feb;46(2):261-6.

10.

Radioprotection of salivary glands by amifostine in high-dose radioiodine treatment. Results of a double-blinded, placebo-controlled study in patients with differentiated thyroid cancer.

Bohuslavizki KH, Klutmann S, Brenner W, Kröger S, Buchert R, Bleckmann C, Mester J, Henze E, Clausen M.

Strahlenther Onkol. 1999 Nov;175 Suppl 4:6-12.

PMID:
10584133
11.

Systematic evaluation of salivary gland damage following I-131 therapy in differentiated thyroid cancer patients by quantitative scintigraphy and clinical follow-up.

Wu JQ, Feng HJ, Ouyang W, Sun YG, Chen P, Wang J, Xian JL, Huang LH.

Nucl Med Commun. 2015 Aug;36(8):819-26. doi: 10.1097/MNM.0000000000000325.

PMID:
25932534
12.

Radioprotection of salivary glands by S-2-(3-aminopropylamino)-ethylphosphorothioic (amifostine) obtained in a rabbit animal model.

Bohuslavizki KH, Klutmann S, Jenicke L, Brenner W, Feyerabend B, Henze E, Clausen M.

Int J Radiat Oncol Biol Phys. 1999 Aug 1;45(1):181-6.

PMID:
10477022
14.

Salivary gland injury resulting from exposure to radioactive iodine: case reports.

Mandel L, Liu F.

J Am Dent Assoc. 2007 Dec;138(12):1582-7.

PMID:
18056102
15.

Assessment of salivary gland dysfunction after radioiodine therapy for thyroid carcinoma using non-contrast-enhanced CT: the significance of changes in volume and attenuation of the glands.

Nabaa B, Takahashi K, Sasaki T, Okizaki A, Aburano T.

AJNR Am J Neuroradiol. 2012 Nov;33(10):1964-70. doi: 10.3174/ajnr.A3063. Epub 2012 May 3.

16.

Sialoendoscopic treatment for radioiodine induced sialadenitis.

Kim JW, Han GS, Lee SH, Lee DY, Kim YM.

Laryngoscope. 2007 Jan;117(1):133-6.

PMID:
17202942
17.

Evidence for early and persistent impairment of salivary gland excretion after irradiation of head and neck tumours.

Liem IH, Olmos RA, Balm AJ, Keus RB, van Tinteren H, Takes RP, Muller SH, Bruce AM, Hoefnagel CA, Hilgers FJ.

Eur J Nucl Med. 1996 Nov;23(11):1485-90.

PMID:
8854847
18.

Does amifostine have radioprotective effects on salivary glands in high-dose radioactive iodine-treated differentiated thyroid cancer.

Ma C, Xie J, Jiang Z, Wang G, Zuo S.

Eur J Nucl Med Mol Imaging. 2010 Aug;37(9):1778-85. doi: 10.1007/s00259-009-1368-6. Epub 2010 Feb 4. Review.

PMID:
20130857
19.

Sialadenitis following I-131 therapy for thyroid carcinoma: concise communication.

Allweiss P, Braunstein GD, Katz A, Waxman A.

J Nucl Med. 1984 Jul;25(7):755-8.

20.

[Quantitative salivary gland scintigraphy--a recommended examination prior to and after radioiodine therapy].

Bohuslavizki KH, Brenner W, Lassmann S, Tinnemeyer S, Kalina S, Clausen M, Henze E.

Nuklearmedizin. 1997 Apr;36(3):103-9. German.

PMID:
9162904
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk